CIA
TMO icon

Capital Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Capital Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$736K Sell
1,467
-197
-12% -$94.6K 0.01% 433
2026
Q1 		$818K Buy
1,664
+195
+13% +$106K 0.01% 382
2025
Q4 		$851K Buy
1,469
+59
+4% +$33.4K 0.01% 370
2025
Q3 		$684K Buy
1,410
+130
+10% +$60.5K 0.01% 415
2025
Q2 		$519K Sell
1,280
-87
-6% -$36.4K 0.01% 450
2025
Q1 		$680K Buy
1,367
+32
+2% +$17.3K 0.01% 385
2024
Q4 		$695K Buy
1,335
+178
+15% +$97.9K 0.01% 367
2024
Q3 		$716K Sell
1,157
-1
-0.1% -$592 0.01% 352
2024
Q2 		$641K Sell
1,158
-723
-38% -$414K 0.01% 357
2024
Q1 		$1.09M Sell
1,881
-34
-2% -$19.1K 0.03% 280
2023
Q4 		$1.02M Sell
1,915
-99
-5% -$47.9K 0.03% 274
2023
Q3 		$1.02M Sell
2,014
-11
-0.5% -$5.86K 0.03% 260
2023
Q2 		$1.06M Sell
2,025
-40
-2% -$21.6K 0.03% 236
2023
Q1 		$1.19M Buy
2,065
+92
+5% +$51.9K 0.04% 227
2022
Q4 		$1.09M Buy
1,973
+66
+3% +$35K 0.03% 241
2022
Q3 		$967K Sell
1,907
-2
-0.1% -$1.12K 0.03% 245
2022
Q2 		$1.04M Buy
1,909
+851
+80% +$468K 0.03% 243
2022
Q1 		$625K Buy
1,058
+6
+0.6% +$3.45K 0.02% 333
2021
Q4 		$702K Buy
1,052
+2
+0.2% +$1.25K 0.02% 328
2021
Q3 		$600K Sell
1,050
-60
-5% -$32.9K 0.02% 342
2021
Q2 		$560K Buy
1,110
+15
+1% +$7.08K 0.02% 352
2021
Q1 		$500K Buy
1,095
+2
+0.2% +$955 0.02% 346
2020
Q4 		$509K Buy
1,093
+373
+52% +$175K 0.02% 331
2020
Q3 		$318K Sell
720
-14
-2% -$5.78K 0.02% 377
2020
Q2 		$266K Hold
734
– – 0.01% 403
2020
Q1 		$208K Buy
734
+65
+10% +$20.5K 0.01% 416
2019
Q4 		$217K Buy
+669
New +$203K 0.01% 472
2019
Q2 		– Sell
-740
Closed -$203K – 522
2019
Q1 		$203K Buy
+740
New +$184K 0.01% 453

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Investment Advisors's TMO Position: Q2 2026 in Review

Capital Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, selling an estimated $94.6K and leaving 1,467 shares worth $736K. The position accounts for 0.01% of the portfolio, ranked #433.

Capital Investment Advisors first reported a position in TMO in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.19M in Q1 2023. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Capital Investment Advisors held 1,467 shares of Thermo Fisher Scientific worth $736K as of Q2 2026.
  • Capital Investment Advisors sold 197 Thermo Fisher Scientific shares in Q2 2026, an estimated $94.6K.
  • Thermo Fisher Scientific made up 0.01% of Capital Investment Advisors's portfolio in Q2 2026, its #433 holding.
  • Capital Investment Advisors first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 28 quarters since.
  • Capital Investment Advisors's Thermo Fisher Scientific position peaked at $1.19M in Q1 2023.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Capital Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.